DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Strengthening capabilities in Peptide Therapeutics and CDMO services
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The freshly infused capital will primarily be deployed towards expansion and research & development
This e-commerce platform is launched as a hyperlocal model
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Subscribe To Our Newsletter & Stay Updated